Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
Open Access
- 26 June 2019
- journal article
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 18 (3) , 28-39
Abstract
Безопасность и иммуногенность полностью жидкой шестивалентной вакцины АбКДС-ИПВ-ГепВ-Hib у здоровых детей 1-го года жизни в Российской ФедерацииKeywords
This publication has 25 references indexed in Scilit:
- Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™) following primary series administration at 2, 4, 6 months of age in Latin AmericaVaccine, 2013
- Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin AmericaThe Pediatric Infectious Disease Journal, 2012
- Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)Cochrane Database of Systematic Reviews, 2012
- Antibody Persistence After a Primary Series of a New DTaP-IPV-Hep B-PRP-T Combined Vaccine or Separate DTaP-IPV//PRP-T and Hepatitis B Vaccines at 2, 4, and 6 Months of Age and the Effect of a Subsequent DTaP-IPV//PRP-T Booster Vaccination at 18 Months of Age in Healthy Argentinean InfantsThe Pediatric Infectious Disease Journal, 2012
- Routine Newborn Hepatitis B ImmunizationInfectious Diseases in Clinical Practice, 2011
- Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2-, 4-, and 6-month-old Argentinean InfantsThe Pediatric Infectious Disease Journal, 2011
- Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infantsInternational Journal of Infectious Diseases, 2011
- Immunogenicity and Safety of an Investigational Fully Liquid Hexavalent Combination Vaccine Versus Licensed Combination Vaccines at 6, 10, and 14 Weeks of Age in Healthy South African InfantsThe Pediatric Infectious Disease Journal, 2011
- Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 yearsVaccine, 2010
- Pertussis VaccineThe Pediatric Infectious Disease Journal, 2009